Denosumab and giant cell tumour of bone-a review and future management considerations.
about
A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With DenosumabRapid skeletal turnover in a radiographic mimic of osteopetrosis.Metachronous multicentric giant cell tumour in a young woman.'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab.Inferior Vena Caval Tumor Thrombus in Giant Cell Tumor of Sacrum - An Unusual Complication Treated with Multimodality Management.Epidemiological study on giant cell tumor recurrence at the Brazilian National Institute of Traumatology and Orthopedics.Neurological Recovery in Two Patients with Cauda Equina Syndrome Secondary to L5 Lumbar Spine Giant Cell Tumour after Treatment with Denosumab without Surgery.Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.RANK pathway in giant cell tumor of bone: pathogenesis and therapeutic aspects.Surveillance for lung metastasis from giant cell tumor of bone.Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.Fibrous dysplasia of bone: craniofacial and dental implications.Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab.Histological Regression of Giant Cell Tumor of Bone Following RANK Ligand Inhibition.Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: A case reportInterventions for managing medication-related osteonecrosis of the jaw.Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.Magnetic resonance imaging aspects of giant-cell tumours of bone.Giant Cell Tumor of the Lateral Skull Base: Diagnostic and Management Options.Improvement of Giant Cell Lesions of the Jaw Treated With High and Low Doses of Denosumab: A Case SeriesCustom 3D-printed finger proximal phalanx as salvage of limb function after aggressive recurrence of giant cell tumour
P2860
Q27000565-8AA98DDE-F9BA-41A4-A5BE-5853C6402BFEQ35343702-D4A332D7-6D71-43D8-B84A-AB334603E9F2Q35614714-91A8F8CA-50F0-4B58-ABDB-2BA81B4A12D4Q35915694-9CF49B90-41F5-4151-829D-1AD35836ACDBQ36836913-66D9CAD1-DD3A-4975-B411-B9A437C9FBB7Q37153068-1BF99231-788C-43E4-9518-55D605288986Q37368567-07EDE93E-5DB8-4CE3-8C22-C3F1F66672C6Q37728606-7BE39D5E-F19B-44D3-923F-44A3A439B121Q38331262-ED37459C-0559-4DE1-B98E-242AF12941CAQ38709020-DD8C3ED8-4B22-4EAB-B0FE-6B3BD8A90750Q38834385-CE7E63D0-8B0D-422F-841A-5153EEE64FFEQ38919235-3C3E46BD-C2D0-46C1-8AA2-14D6DF02F213Q40713943-BEB69E84-C9BE-44C1-8CFE-85A3F0A36F5CQ41781640-E1577D8B-5E12-4682-B5CA-6F4E7A41EC3AQ42184417-76EB11A6-C851-4EEE-9116-2FD94FAA78F9Q42695284-28D2A11F-E4CA-4AAF-862D-AA39048D3916Q46296494-D123B413-FDCC-4FE6-BC12-554AF3A57237Q53154986-B44D5442-6CD2-4E39-96F6-95A46D6E8F67Q55340833-E327FF75-C4CD-4489-9671-AD761FA28D3AQ57152780-C3FA0428-DE8B-4D71-8A33-B537732022E9Q58724619-1C7AE5C7-4FD1-4918-BA00-7CA3E2C0BE26
P2860
Denosumab and giant cell tumour of bone-a review and future management considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Denosumab and giant cell tumour of bone-a review and future management considerations.
@en
Denosumab and giant cell tumour of bone-a review and future management considerations.
@nl
type
label
Denosumab and giant cell tumour of bone-a review and future management considerations.
@en
Denosumab and giant cell tumour of bone-a review and future management considerations.
@nl
prefLabel
Denosumab and giant cell tumour of bone-a review and future management considerations.
@en
Denosumab and giant cell tumour of bone-a review and future management considerations.
@nl
P2093
P2860
P356
P1433
P1476
Denosumab and giant cell tumour of bone-a review and future management considerations.
@en
P2093
P2860
P304
P356
10.3747/CO.20.1497
P577
2013-10-01T00:00:00Z